Please login to the form below
Germany
This page shows the latest Germany news and features for those working in and with pharma, biotech and healthcare.
Bayer axes 1,250 pharma jobs, with R&D taking the brunt
Around 900 jobs will go across the Germany group’s pharma R&D operations, out of 12, 000 losses in total from its current headcount of around 118, 000.
Latest news
-
Vertex rises on data for cystic fibrosis triple therapy
90% discount on what Germany pays for one of Vertex’s medicines.
-
Reference price bill tabled in US House and Senate
the UK, France, Germany and Japan.
-
MPs threaten to publish Vertex’s Orkambi price if no deal struck
on what Germany pays for one of Vertex’s medicines.
-
Q&A: Beth Whitworth
Set in Nazi Germany in World War II, it’s a beautiful piece of storytelling that is thought-provoking and harrowing, yet triumphant.
-
AZ says target of $45bn sales by 2023 still achievable
patient prescriptions in the US and Germany and topping all biologics for asthma on that measure in Japan.
More from news
Approximately 42 fully matching, plus 775 partially matching documents found.
Latest Intelligence
-
Five questions guiding the way to actual patient-centricity
By Andreas Reinbolz, Managing Director and Daniel Schäfer, Senior Digital Strategist, both at Syneos Health Communications Germany.
-
In conversation with Pfizer’s Erik Nordkamp
I’ve had the privilege of working in Belgium, Germany and Greece, as well as in the UK. ... Belgium and Germany often appear near the top of international league tables when it comes to health.
-
Alnylam’s big moment: bringing groundbreaking RNAi drugs to Europe
The drug has now been launched in the US, where it has a list price of $450, 000 per patient per year and in Germany, its first European launch market, where ... Onpattro got its first European launch in Germany in early October, where the drug’s high
-
KAM 2.0
The Fresenius Helios hospital group, based in Germany, recently acquired the Spanish hospital group Grupo Hospitalario Quirónsalud to become the largest hospital group in Europe.
-
The race for a HIV ‘cure’
Sure, it might be easier to work in the UK, France or Germany but that doesn’t mean we don’t work at the same speed for other countries.
More from intelligence
Approximately 9 fully matching, plus 112 partially matching documents found.
Latest appointments
-
Richard Paulson joins Ipsen as CEO for North America
During a 10-year career at Amgen, Paulson held a number positions at the company, including general manager of Germany and general manager of central and eastern Europe.
-
Dave Lemus joins Proteros as an executive board member
He joins the German biotech’s board from Medigene. Proteros, a private biotech based in Germany, has appointed Dave Lemus as an executive board member, chief operating officer and chief financial
-
MC Services welcomes Dr Claudia Gutjahr-Loeser to its management team
She joins the Duesseldorf, Germany-based firm from MorphoSys, where she headed the corporate communications and investor relations department as senior vice president; a role that saw her took responsibility for
-
Paolo Carli appointed as head of MEA at Merck
He will be responsible for leading commercial operations. Germany's Merck has appointed Paolo Carli as its new head of healthcare business, taking the helm of its commercial operations for the ... Carli joined Merck in 2009 as a member of the mergers and
-
Almirall appoints Peter Guenter as its CEO
He previously held many senior positions at Sanofi, including vice president Eastern Europe and Northern Europe, vice president business management and support, general manager, Germany, and senior vice president, Europe.
More from appointments
Approximately 2 fully matching, plus 73 partially matching documents found.
Latest from PMHub
-
Research Partnership opens new office in Lyon, France
She will have a remit to grow and expand the Lyon office as well as to service existing clients based in France, Switzerland and Germany.
-
Attracting and retaining talent – recruiting the workforce of the future
They polled over 6, 600 employees from Australia, Canada, France, Germany, the Netherlands, Scandinavia, Spain, the UK, and the United States.
-
Acute leukaemia patients get new online information centre that will help them get the best possible care
Most importantly, the panel of experts from the UK, Italy, France, Spain, Germany, Canada and the US provides insights into how to get the best from a healthcare team, including what
-
Clinical and Diagnostics Center
We collaborate with foreign companies from the France, Germany, USA, Great Britain, Switzerland, Spain, Sweden, Poland, Latvia, Croatia, Russia.
-
How to break down the barriers to patient enrolment
In a survey of more than 360 healthcare professionals (HCPs) in France, Germany, the United Kingdom, and the United States, just 40% reported being ‘very aware’ of pharmaceutical companies' patient services.
More from PMHub
Approximately 1 fully matching, plus 65 partially matching documents found.
Featured jobs
-
Medical Writer
-
Bonus Scheme, PTO &Private Healthcare
- Account Manager / Senior Account Manager
-
35, 000-40, 000
- Principal Health Economist - North-West
-
Negotiable
-
Medical (Scientific) Director
-
£120, 000 benefits
-
Business Director
-
Competitive Salary Offered
- Scientific Director – Medical Communications - New York or Remot...
-
$100000 - $150000
- Business Development Director – Health Education
-
excellent commission
-
Senior Account Manager
-
Competitive Salary Offered
- Account Manager- Healthcare Advertising
-
Negotiable
-
Experienced Medical Writers
-
Competitive Salary and Benefits
- CALLING ALL SENIOR HEALTHCARE PR FREELANCERS!!!!! ACCOUNT DIRECT...
-
EXCELLENT DAY RATES AVAILABLE
-
Account Director
-
Competitive Salary Offered
-
Associate Director
-
£75, 000-90, 000
Subscribe to our email news alerts
- Blue Latitude Health joins Fishawack Group of Companies
- Clark Health Communications to bring AI at the forefront with new deal
- Merck exec steps down, two takes his place
- NICE says no to rival Alnylam and Akcea amyliodsis drugs – but deal could be done
- FDA takes aim at pharma’s biosimilar-delaying tactics
- Circassia seeks shift to AIM after failing LSE criteria
PMHub
Creative Medical Research
Specialising in medical device market research and participant recruitment human factors research, our approach is people-centric. We thrive on making...
Latest intelligence
- Report: Achieving launch excellence in the challenging healthcare markets of today
- Our in-depth report is based on original data and expert interviews, which coupled with our own experience, ensures we give you the best recommendations for achieving launch success in challenging...
- What is blockchain and why should i care - Richard Springham
- Four Health - Emerging Technologies The power of blockchain lies in the fact it can prove that a unique event occurred at a certain time with out the need to...
- NHS medicines optimisation milestone
- Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare Consulting Team, explore the implications of Adalimumab’s recent European patent expiry...
Quick links
Infographics
